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MALIGNANCIES OF THE THYMUS
The Role of Fine Needle Aspiration Cytology in the
Diagnosis and Management of Thymic Neoplasia
Maureen F. Zakowski, MD, James Huang, MD, and Matthew P. Bramlage, MD
Background: Fine needle aspiration biopsy is commonly used to
document the metastasis to the mediastinum. It is less often used to
make the primary diagnosis of tumors, particularly thymic neo-
plasms. This is due to fear of sampling error, rarity of thymic
tumors, multiplicity of lesions in the mediastinum, and inexperience
on the part of the cytopathologist. We show that needle aspiration
sampling of thymic tumors, both thymoma and thymic carcinoma, is
an accurate method of diagnosis.
Methods and Results: In our series of 22 thymic tumors aspirated
preoperatively and compared with the subsequent surgical resection,
the accuracy of a diagnosis of thymoma was 100%, and the accuracy
of a diagnosis of carcinoma was 100%. Difficulties were encoun-
tered when vague terminology was used, and insufficient informa-
tion was conveyed. Immunohistochemical stains can be applied to
cytologic material to aid in the identification of the epithelial and
lymphocytic components of thymoma.
Discussion: Correlation with clinical and radiographic information
is necessary, and wording of the cytology report should be as
complete and clear as possible.
Key Words: Thymoma, Thymic carcinoma, Fine needle aspiration
biopsy, Preoperative, Surgical resection, Immunohistochemical stains.
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The diagnosis of mediastinal lesions can be challenging insurgical pathology material because of the numerous
benign and malignant processes occurring at this site. The use
of fine needle aspiration (FNA) cytology as a diagnostic tool
is even more challenging. Accurate and reliable diagnostic
procedures are necessary in the management of mediastinal
lesions to facilitate timely treatment. FNA is commonly used
to sample tumors in all compartments of the mediastinum,
especially in the setting of metastatic disease, but its utility in
the diagnosis of thymic neoplasm is not well studied. We
have undertaken a retrospective review of thymic neoplasms
diagnosed by FNA and subsequently excised, with an em-
phasis on the accuracy and usefulness of cytology in the
diagnosis and management of thymic epithelial tumors.
Thymoma is a distinctive biphasic tumor containing
neoplastic epithelial cells and benign reactive, immature
T-cell lymphocytes; it is the most common primary malig-
nancy of the anterior mediastinum,1,2 although it can occur in
other compartments and anatomic sites as well. The possibil-
ity of thymoma should be considered in any patient present-
ing with a mediastinal mass. Thymomas are slow growing
tumors with the potential for local extension and late recur-
rence. When metastases occur, they are most frequent in the
pleura, pericardium, and diaphragm.3 Clinically, thymomas
are generally regarded as malignant with varying degrees of
aggressiveness. They are often classified using the WHO
system, although several systems, often overlapping, are in
use. Thymomas are stratified by the WHO into six groups
(types A, AB, B1, B2, B3, and C)4 on the basis of the
morphology of epithelial cells and the lymphocyte-to-epithe-
lial cell ratio. Final pathologic staging is usually done using
the Masaoka staging system on resected tumors. Histologic
classification systems do not correlate well with cytology
findings, and Masaoka staging cannot be applied to a cytol-
ogy specimen because of the inability of cytology to deter-
mine capsular invasion.5–7
Thymic carcinomas are aggressive epithelial malignan-
cies presumed to arise from the native epithelial cells of the
thymus gland. They are not biphasic and are not classified in
a similar fashion to thymomas; rather, they are identified
descriptively according to their morphologic appearance,
such as squamous carcinoma and mucoepidermoid carci-
noma. Confusingly, thymic carcinomas are also called as type
C thymomas in the WHO system.
The cytologic features of thymomas have been de-
scribed previously,5,7–10 but few studies describe the use of
FNA as the primary diagnostic modality. The two compo-
nents of thymoma, epithelial cells and lymphocytes, may vary
in quantity, and the epithelial cells may show inconsistency in
size and shape as well as number. Recognition of the biphasic
nature of thymomas is necessary for making the correct
diagnosis, especially in cytologic preparations where the
material may be limited or sampling suboptimal. Failure to do
so can lead to the incorrect interpretation of thymoma as
benign or malignant lymphoid lesions; similarly, an epithelial
predominant thymoma may be incorrectly diagnosed as a
carcinoma or even a sarcoma. Immunohistochemical (IHC)
studies are helpful in supporting the cytomorphologic impres-
sion, both by characterizing the epithelial component as
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thymic in origin and by demonstrating the immature T-cell
phenotype of the admixed reactive lymphocytes.
Because of the rarity of these tumors and the subse-
quent inexperience of cytopathologists, the confusing mor-
phologic picture, and the inability to apply Masaoka staging
to cytologic material, FNA biopsy may be underused in the
diagnosis and treatment of thymic neoplasia. The lack of
understanding or confidence of the clinician as to the useful-
ness of mediastinal FNA to establish primary disease may
also be a limiting factor. Nevertheless, we consider FNA to
be an accurate and useful tool in the clinical setting of
thymoma.
MATERIALS AND METHODS
Twenty-two mediastinal fine needle aspirations (FNAMs)
and corresponding surgical resections from 22 patients were
retrieved from the files of the Pathology Department of Memo-
rial Sloan-Kettering Cancer Center. Cases were identified by
searching the files from 1997 to 2006 for surgically resected
thymic tumors with antecedent corresponding cytology spec-
imens. All procedures were performed at a single institution.
Consultation cases received from outside institutions were
not included in the series. Only untreated primary tumors in
the mediastinum identified by prior imaging were included,
thus the FNAM represented the initial diagnostic procedure.
FNAMs were performed by image-guided transthoracic
FNA. Diff-Quik (Baxter Diagnostics, Miami, FL) -stained
smears were prepared, and specimen adequacy was deter-
mined at the time of procedure by on-site cytotechnologists.
Additional smears were fixed in 95% alcohol, and the aspi-
ration needle was rinsed in CytoLyt fixative (Cytyc Corpo-
ration, Boxborough, MA). Alcohol-fixed smears were stained
either by the Papanicolaou technique or with hematoxylin and
eosin. A Papanicolaou-stained ThinPrep slide was prepared
from the CytoLyt-fixed needle rinse. A cell block was pre-
pared if sufficient material was present. Immunohistochem-
istry was performed on either additional ThinPrep slides or
cell block material. The surgical specimens were fixed in
10% formalin, processed in the routine fashion, and embed-
ded in paraffin. Four-micrometer thick sections were cut and
stained with hematoxylin and eosin.
All cytology slides were blindly reviewed by a senior
cytopathologist (M.F.Z.), and the surgical slides were re-
viewed by a senior thoracic pathologist (M.F.Z.). The surgi-
cal resections were reclassified in accordance with the 2004
WHO guidelines. The cytology slides and surgical slides
were compared in cases of diagnostic discrepancy. Both the
original and review diagnoses were recorded for each case
(Table 1).
RESULTS
The age range in the series was 42 to 82 years, and the
mean age was 60 years; 12 patients were women, and 10 were
men. Eighteen cases were thymoma and four were thymic
carcinoma: three squamous cell type and one lymphoepithe-
lial carcinoma. For the four cases of thymic carcinoma, there
were four male patients and one female patient; average age
was 58 years. Both the youngest (42 years) and the oldest
patients (82 years) in the series had thymic malignancies. The
thymomas included WHO type A (one), B2 (six), B3 (two),
B1/B2 (four), AB1 (two), AB2 (two), and micronodular type
(one) by final reviewed histologic diagnoses. No pure type B1
was identified. These diagnoses were almost in exact concor-
dance with the original histologic diagnoses.
The original cytologic diagnoses were less specific and
never included the WHO subtype.
On review of the cytology, 17 cases were called thy-
moma/suspect thymoma. Of these 17 cases, all were con-
firmed thymoma by histology. Three cases called squamous
cell carcinoma/suspect squamous cell carcinoma on cytology
were confirmed as thymic carcinoma, squamous cell type on
histology. One case diagnosed as “malignant neoplasm with
necrosis” on cytology proved to be a B1/B2 thymoma on
resection, and one case called “B3 thymoma v well differen-
tiated adenocarcinoma” on cytology was a tissue-confirmed
B2 thymoma.
This cytology diagnoses, made on blinded review, did
not differ significantly from the original cytology interpreta-
tions. The cytology review diagnoses were more specific than
the original interpretations.
There were six cases that were discordant in part or
whole between initial cytology diagnosis and cytology re-
view/surgical pathology diagnosis. Case 9 called “negative
for malignancy,” not further specified, was called consistent
with thymoma on cytology review and proved to be a B1/B2
thymoma on histology. Case 11 called “suspect spindle cell
neoplasm” was a spindle cell thymoma on review and on
subsequent resection (Figure 1). Case 14 called originally
“atypical lymphoid population” was misclassified on cytol-
ogy review as “suspect thymoma” and tissue proven to be a
lymphoepithelial carcinoma. Case 17 was called “neoplastic
cells present” on the original cytology, and diagnosis was
deferred to the concurrent core biopsy. The core biopsy
demonstrated a thymic carcinoma, squamous cell type. Case
18 was called “malignant epithelial neoplasm” originally and
reviewed as a thymoma. The original cytology description of
case 20 favored “carcinoma over thymoma” and was diag-
nosed as thymoma on review of the cytology and by tissue
(Figure 2). Of the six discrepant cases described above, there
was only one case (9) that was actually incorrect, where
cytology was not helpful in achieving a preoperative diagno-
sis, making the usefulness of a cytologic diagnosis 95%. The
specificity of the cytologic diagnoses was lower. Case 17 was
diagnosed as neoplastic and as such, provided correct, albeit,
limited information to the clinician.
On the basis of our blinded review of the cases, the
predictive value of a cytologic diagnosis of thymoma was
100%, and the predictive value of a diagnosis of carcinoma
was 100%; however, there were several cases where the exact
classification was not made on the cytologic specimen.
Difficulties arose with the correct identification of tumor
type when necrosis, which is correlated with malignancy,7 was
present (case 2), and with an epithelial-rich thymoma (case
12) where the epithelial component was predominately aspi-
rated and the lymphoid component was overlooked, case 14
was misdiagnosed originally and on review, perhaps due to
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the difficulty in recognizing the appearance of a tumor as rare
as a lymphoepithelial carcinoma. The original cytology in-
terpretations, made by at least six different cytologists with
varying degrees of experience, were less specific than the
review diagnoses and, therefore, less clinically useful but not
technically incorrect.
DISCUSSION
Multiple techniques have been used for the pathologic
diagnosis of thymic tumors, including computed tomogra-
phy-guided core biopsy, mediastinoscopy, mediastinotomy,
and thoracoscopy. These techniques, although effective, are
relatively invasive, with complication rates ranging from 1 to
3%.11 With image guidance, it is possible to perform FNA
biopsy of mediastinal lesions (FNAM) with reduced compli-
cation rates and avoidance of a diagnostic thoracotomy.
Although FNA biopsies are widely accepted for vis-
ceral organs, they are not generally well accepted in the
mediastinum. As noted earlier in the text, this may be due to
the inexperience of cytologists and/or the lack of confidence
on the part of the clinician with the usefulness of mediastinal
FNA to establish primary disease. FNAM is better accepted
in the documentation of suspected metastatic disease to the
mediastinum in the setting of a known primary.6
The literature suggests a fairly wide range of reliability
for FNAM. Published accuracies range from 77 to 100%,2,6,11
TABLE 1. Cytologic and Histologic Diagnoses of Cases Studied
Case Gender
Age
(yr) Specimen
Original Cytology
Diagnosis
Cytology Diagnosis
on Review
Original Surgical
Diagnosis
Surgical Diagnosis on
Review
1 F 52 FNAM Suspect thymoma Thymoma B3 thymoma B3 thymoma
2 F 57 FNAM Suspect malignant
neoplasm
Malignant neoplasm
with necrosis
B1 thymoma B1/B2 thymoma
3 F 55 FNAM Suspect spindle cell
neoplasm
Spindle cell thymoma A thymoma A thymoma
4 F 59 FNAM Suspect thymoma Thymoma B2 thymoma Micronodular thymoma
with lymphoid
hyperplasia
5 F 74 FNAM Suspect thymoma Thymoma B2/B3 thymoma B3 thymoma
6 M 68 FNAM Suspect thymic
neoplasm
Thymoma AB thymoma AB1B2 thymoma
7 M 53 FNAM Thymoma Thymoma AB thymoma AB2 thymoma
8 M 54 FNAM Suspect thymoma Thymoma B2 thymoma B2 thymoma
9 F 75 FNAM Negative for
malignancy
Consistent with
thymoma
B1 thymoma B2/B1 thymoma
10 F 42 FNAM Suspect malignant
neoplasm
Suspect squamous cell
carcinoma
Poorly differentiated
carcinoma
Squamous cell
carcinoma with
squamoid features
11 F 46 FNAM Suspect spindle cell
neoplasm
Suspect thymoma AB1 thymoma AB1 thymoma
12 F 46 FNAM Adenocarcinoma B3 thymoma versus
well
B2 thymoma B2 thymoma
differentiated
adenocarcinoma
13 M 71 FNAM Suspect thymoma Thymoma B2 thymoma B2/B1 thymoma
14 M 82 FNAM Atypical lymphoid
population
Suspect thymoma Thymic carcinoma, Lymphoepithelioma
lymphoepithelial type
15 F 71 FNAM Atypical, suggestive of
thymic
Suspect thymoma A thymoma A/B2 thymoma tissue,
cannot rule out
thymoma
16 M 66 FNAM Squamous cell
carcinoma
Squamous cell
carcinoma
Squamous cell
carcinoma
Squamous cell
carcinoma
17 M 44 Neoplastic cells
present
Squamous cell
carcinoma
Squamous cell
carcinoma
Squamous cell
carcinoma
18 M 67 FNAM Malignant epithelial
neoplasm
Thymoma B2 thymoma B2 thymoma
19 F 74 FNAM Suspect thymoma Thymoma AB thymoma A/B1 with micronodular
thymoma with
lymphoid hyperplasia
20 F 42 FNAM Favor carcinoma over
thymoma
Thymoma lymphocyte-rich
thymoma
B2 thymoma
21 M 76 FNAM Thymoma Thymoma Mixed type thymoma B2 thymoma
22 M 49 FNAM Thymoma Thymoma B2 thymoma B2/A thymoma
FNAM, mediastinal fine needle aspiration.
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sensitivities range from 71 to 87%,2,5 and positive predictive
values range from 69 to 100%.2
Diagnostic pitfalls have been previously noted in the
evaluation of thymic neoplasms by FNAM. Many of these
pitfalls can be overcome by proper sampling and the appro-
priate use of ancillary studies. If the epithelial component of
lymphocyte-rich thymomas (such as WHO type B1) is not
identified, the specimen may seem to represent a benign
lymph node, a reactive process, or even a lymphoma. This
problem can occur if the epithelial component is scant and
overlooked, or misinterpreted as germinal centers or granu-
lomas. In some cases, the epithelial component may be absent
due to poor sampling. When the presence of epithelial cells is
suspected, a cytokeratin IHC stain should be used (Figure 3).
Spindle cell thymomas (WHO type A or AB) can be misi-
dentified as another spindle cell lesion, such as carcinoid,
low-grade sarcoma, or misinterpreted, as the sclerosis seen in
a large cell lymphoma.
Thymic carcinomas are often morphologically and im-
munohistochemically indistinguishable from a metastatic car-
cinoma. An example of this is an FNAM showing a squa-
mous carcinoma (Figure 4). In this case, the tumor may
represent a primary thymic carcinoma or perhaps a lung
carcinoma with either local extension into the mediastinum or
metastasis to a mediastinal lymph node. In many cases, the
origin of the carcinoma cannot be determined on morphologic
or IHC grounds alone. Another area of difficulty in FNA
FIGURE 3. Case 12: Immunohistochemical (IHC) stain for
cytokeratin on an fine needle aspiration (FNA) specimen
demonstrating the (brown) positivity for keratin in the back-
ground of reactive lymphocytes.
FIGURE 4. Case 16: Cell block preparation showing large
eosinophilic cells of thymic carcinoma, squamous cell type.
Hematoxylin and eosin (H&E) stain.
FIGURE 2. Case 20: Fine needle aspiration (FNA) of a lym-
phocyte-rich thymoma, type B2 where the majority of the
cells are reactive lymphocytes, and fewer epithelial cells are
seen. Diff-Quik stain.
FIGURE 1. Case 11: Fine needle aspiration (FNA) of an AB1
thymoma originally diagnosed on cytology as a spindle cell
neoplasm. Note the predominance of cohesive spindle-
shaped epithelial cells and the relatively inconspicuous lym-
phocytes. Hematoxylin and eosin (H&E) stain.
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biopsy of mediastinal tumors is the misidentification of a
germ cell tumor as a thymic carcinoma. In this case, proper
sampling combined with IHC stains should clarify the dis-
tinction.
We agree with the literature that FNA is vastly under-
used as a diagnostic technique for mediastinal masses in
general and for thymic epithelial neoplasms specifically.5,11
Percutaneous FNAM is diagnostic in a sufficiently large
number of cases11,12 to make it the primary modality in the
work up of suspected thymomas. Attempts at subtyping
thymomas on cytology are probably not worthwhile, and if a
pathologist is able to confidently issue a diagnosis of thy-
moma on FNA, this information should suffice to direct
management.2
According to our experience and that of others, we
believe that thymic neoplasms are distinguishable from the
majority of other lesions of the mediastinum by FNA biopsy,2,7
especially when it is correlated with clinical and radiologic
findings.8
Of note, in all but two of our cases (2 and 13), the FNA
diagnosis on review was accurate and correlated well with the
surgical sample.
Interestingly, difficulty in diagnosis due to sampling error
played a minor role in our series. Therefore, it is assumable that
the experience of the pathologist played a role.
We recommend that FNAM be the first diagnostic test
performed in the scenario of a mass occupying mediastinal
lesion, including cases where thymic neoplasia is a clinical
consideration. The accuracy of the diagnosis of thymic neo-
plasia rests in part on the experience of the cytopathologist,
and a central registry or review of such specimens is not an
unreasonable proposition. Nevertheless, as we have shown,
the confidence level of a report of thymoma is high, and the
use of FNA should be encouraged in this setting. Further-
more, we believe that cytopathologic terminology should be
as specific as possible to convey an accurate picture to the
treating physician. The use of vague terminology such as
“neoplasm,” not further described, is to be discouraged.
Clinical and radiographic correlation with the FNAM is
essential. Cytology plays little, if any, role in the WHO
subtyping or the Masaoka staging of thymomas.
REFERENCES
1. Singh HK, Silverman JF, Powers CN, et al. Diagnostic pitfalls in
fine-needle aspiration biopsy of the mediastinum. Diagn Cytopathol
1997;17:121–126.
2. Ali SZ, Erozan YS. Thymoma. Cytopathologic features and differential
diagnosis on fine needle aspiration. Acta Cytol 1998;42:845–854.
3. Falkson CB, Bezjak A, Darling G, et al. Lung Cancer Disease Site
Group of Cancer Care Ontario’s Program in Evidence-Based Care. The
management of thymoma: a systematic review and practice guideline.
J Thorac Oncol 2009;4:911–919.
4. Travis WD, Brambilla E, Muller-Hermelink HK (Eds), World Health
Organization Classification of Tumours. Pathology and Genetics of
Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC
Press, 2004.
5. Wakely PE Jr. Fine needle aspiration in the diagnosis of thymic epithe-
lial neoplasms. Hematol Oncol Clin North Am 2008;22:433–442.
6. Goel D, Prayaga AK, Sundaram C, et al. Utility of fine needle aspiration
cytology in mediastinal lesions: a clinicopathologic study of 1617 cases
from a single institution. Acta Cytol 2008;52:404–411.
7. Chhieng DC, Rose D, Ludwig ME, et al. Cytology of thymomas:
emphasis on morphology and correlation with histologic subtypes.
Cancer 2000;90:24–32.
8. Shin HJ, Katz RL. Thymic neoplasia as represented by fine needle
aspiration biopsy of anterior mediastinal masses. A practical approach to
the differential diagnosis. Acta Cytol 1998;42:855–864.
9. Slagel DD, Powers CN, Melaragno MJ, et al. Spindle-cell lesions of the
mediastinum: diagnosis by fine-needle aspiration biopsy. Diagn Cyto-
pathol 1997;17:167–176.
10. Sherman ME, Black-Schaffer S. Diagnosis of thymoma by needle
biopsy. Acta Cytol 1990;34:63–68.
11. Assaad MW, Pantanowitz L, Otis CN. Diagnostic accuracy of image-
guided percutaneous fine needle aspiration biopsy of the mediastinum.
Diagn Cytopathol 2007;35:705–709.
12. Geisinger KR. Differential diagnostic considerations and potential pit-
falls in fine-needle aspiration biopsies of the mediastinum. Diagn Cyto-
pathol 1995;13:436–442.
Journal of Thoracic Oncology • Volume 5, Number 10, Supplement 4, October 2010 Role of Fine Needle Aspiration Cytology
Copyright © 2010 by the International Association for the Study of Lung Cancer S285
